Recherche - Archive ouverte HAL

75 résultats

	Pour les 75 documents Envoyer sur ORCID RSS ATOM Exporter BibTeX XML-TEI CSV RTF EndNote PDF HTML Export avancé	Page : Page précédente 1 2 3 Page suivante	triés par Pertinence Auteur A→Z Auteur Z→A Titre A→Z Titre Z→A Date de publication croissante Date de publication décroissante Date de dépôt croissante Date de dépôt décroissante

		Embedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experience Pierre-François Dequin , Amélie Le Gouge , Elsa Tavernier , Bruno Giraudeau , Sarah Zohar Statistics in Biopharmaceutical Research, 2020, 12 (4), pp.478-482. ⟨10.1080/19466315.2020.1800509⟩ Article dans une revue hal-03122980v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Coping with Information Loss and the Use of Auxiliary Sources of Data: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions Silvia Calderazzo , Sergey Tarima , Carissa Reid , Nancy Flournoy , Tim Friede , et al. Statistics in Biopharmaceutical Research, 2023, pp.1-17. ⟨10.1080/19466315.2023.2211023⟩ Article dans une revue hal-04336804v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		dfcomb: An R-package for phase I/II trials of drug combinations Marie-Karelle Riviere , Jacques-Henri Jourdan , Sarah Zohar Computer Methods and Programs in Biomedicine, 2016, 125, pp.117-133. ⟨10.1016/j.cmpb.2015.10.018⟩ Article dans une revue hal-01297367v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Dose-finding methods for Phase I clinical trials using pharmacokinetics in small populations Moreno Ursino , Sarah Zohar , Frederike Lentz , Corinne Alberti , Tim Friede , et al. Biometrical Journal, 2017, 59 (4), pp.804-825. ⟨10.1002/bimj.201600084⟩ Article dans une revue hal-01560222v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Designs of drug-combination phase I trials in oncology: a systematic review of the literature Marie-Karelle Riviere , C. Le Tourneau , X. Paoletti , F. Dubois , Sarah Zohar Annals of Oncology, 2015, 26 (4), pp.669-674. ⟨10.1093/annonc/mdu516⟩ Article dans une revue hal-01298650v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		A dose finding design for seizure reduction in neonates Moreno Ursino , Ying Yuan , Corinne Alberti , Emmanuelle Comets , Geraldine Favrais , et al. Journal of the Royal Statistical Society: Series C Applied Statistics, 2019, 68 (2), pp.427-444. ⟨10.1111/rssc.12289⟩ Article dans une revue hal-03862983v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Using the continual reassessment method to estimate the minimum effective dose in phase II dose-finding studies: a case study Sarah Zohar , Matthieu Resche-Rigon , Sylvie Chevret Clinical Trials, 2013, 10 (3), pp.414-421. ⟨10.1177/1740774511411593⟩ Article dans une revue inserm-02456741v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		A straightforward meta‐analysis approach for oncology phase I dose‐finding studies Christian Röver , Moreno Ursino , Tim Friede , Sarah Zohar Statistics in Medicine, 2022, 41 (20), pp.3915-3940. ⟨10.1002/sim.9484⟩ Article dans une revue hal-03864767v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditions Steffen Unkel , Christian Röver , Nigel Stallard , Norbert Benda , Martin Posch , et al. Orphanet Journal of Rare Diseases, 2016, 11, pp.16. ⟨10.1186/s13023-016-0402-6⟩ Article dans une revue hal-01286678v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Designing a paediatric study for an antimalarial drug including prior information from adults Caroline Petit , Vincent Jullien , Adeline Samson , Jérémie Guedj , Jean-René Kiechel , et al. Antimicrobial Agents and Chemotherapy, 2016, 60 (3), pp.1481-1491. ⟨10.1128/AAC.01125-15⟩ Article dans une revue hal-01255863v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Estimating Similarity of Dose–Response Relationships in Phase I Clinical Trials—Case Study in Bridging Data Package Adrien Ollier , Sarah Zohar , Satoshi Morita , Moreno Ursino International Journal of Environmental Research and Public Health, 2021, 18 (4), pp.1639. ⟨10.3390/ijerph18041639⟩ Article dans une revue hal-03878713v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Application of the Continual Reassessment Method to Dose-finding Studies in Regional Anesthesia Abhinav Kant , Pawan Kumar Gupta , Sarah Zohar , Sylvie Chevret , Philip Hopkins Anesthesiology, 2013, 119 (1), pp.29-35. ⟨10.1097/ALN.0b013e31829764cf⟩ Article dans une revue inserm-02456728v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Bayesian variable selection based on clinical relevance weights in small sample studies—Application to colon cancer Sandrine Boulet , Moreno Ursino , Peter F Thall , Anne-Sophie Jannot , Sarah Zohar Statistics in Medicine, 2019, 38 (12), pp.2228-2247. ⟨10.1002/sim.8107⟩ Article dans une revue hal-02120840v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Planning a Bayesian early-phase phase I/II study for human vaccines in HER2 carcinomas Sarah Zohar , Ileana Baldi , Guido Forni , Franco Merletti , Giuseppe Masucci , et al. Pharmaceutical Statistics, 2011, 10 (3), pp.218-226. ⟨10.1002/pst.450⟩ Article dans une revue istex inserm-02456773v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Incorporating lower grade toxicity information into dose finding designs Alexia Iasonos , Sarah Zohar , John O'Quigley Clinical Trials, 2011, 8 (4), pp.370-379. ⟨10.1177/1740774511410732⟩ Article dans une revue inserm-02456758v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Hematopoietic progenitor cell mobilization and harvesting in children with malignancies: do the advantages of pegfilgrastim really translate into clinical benefit? Etienne Merlin , Sarah Zohar , C. Jérôme , Richard Veyrat-Masson , Geoffroy Marceau , et al. Bone Marrow Transplantation, 2009, 43 (12), pp.919-25. ⟨10.1038/bmt.2008.412⟩ Article dans une revue inserm-00435572v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Bayesian design and conduct of phase II single-arm clinical trials with binary outcomes: A tutorial Sarah Zohar , Satoshi Teramukai , Yinghui Zhou Contemporary Clinical Trials Communications, 2008, 29 (4), pp.608-616. ⟨10.1016/j.cct.2007.11.005⟩ Article dans une revue inserm-02456790v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Recommendations for the design of therapeutic trials for neonatal seizures Janet S Soul , Ronit Pressler , Marilee Allen , Geraldine Boylan , Heike Rabe , et al. Pediatric Research, 2019, 85 (7), pp.943-954. ⟨10.1038/s41390-018-0242-2⟩ Article dans une revue hal-02149297v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Phase I/II dose-finding design for molecularly targeted agent: Plateau determination using adaptive randomization Marie-Karelle Riviere , Ying Yuan , Jacques-Henri Jourdan , Frédéric Dubois , Sarah Zohar Statistical Methods in Medical Research, 2018, 27 (2), pp.466-479. ⟨10.1177/0962280216631763⟩ Article dans une revue hal-03864773v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Exploring how non-inferiority and equivalence are assessed in paediatrics: a systematic review Camille Aupiais , Sarah Zohar , Garry Taverny , Enora Le Roux , Rym Boulkedid , et al. Archives of Disease in Childhood, 2018, pp.archdischild-2018-314874. ⟨10.1136/archdischild-2018-314874⟩ Article dans une revue hal-03864775v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Approaches to sample size calculation for clinical trials in rare diseases Tim Friede , Corinne Alberti , Norbert Benda , Emmanuelle Comets , Alex Dmitrienko , et al. Pharmaceutical Statistics, 2018, 17 (3), pp.214-230. ⟨10.1002/pst.1848⟩ Article dans une revue inserm-02456642v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Response to comments on ‘Competing designs for drug combination in phase I dose-finding clinical trials’ by G. Yin, R. Lin and N. Wages Marie-Karelle Riviere , Frédéric Dubois , Sarah Zohar Statistics in Medicine, 2015, 34 (1), pp.23-26. ⟨10.1002/sim.6332⟩ Article dans une revue istex hal-01298661v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Comments on ‘A comparative study of adaptive dose-finding designs for phase I oncology trials of combination therapies’ Marie-Karelle Riviere , Sarah Zohar Statistics in Medicine, 2016, 35 (3), pp.475-478. ⟨10.1002/sim.6630⟩ Article dans une revue istex inserm-02456674v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue? Cornelia Ursula Kunz , Silke Jörgens , Frank Bretz , Nigel Stallard , Kelly van Lancker , et al. Statistics in Biopharmaceutical Research, 2020, 12 (4), pp.461-477. ⟨10.1080/19466315.2020.1799857⟩ Article dans une revue hal-03122985v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Dose-finding designs using a novel quasi-continuous endpoint for multiple toxicities Monia Ezzalfani , Sarah Zohar , Rui Qin , Sumithra Mandrekar , Marie-Cécile Le Deley Statistics in Medicine, 2013, 32 (16), pp.2728-2746. ⟨10.1002/sim.5737⟩ Article dans une revue inserm-02456722v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Bayesian dose‐regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics Emma Gerard , Sarah Zohar , Hoai‐thu Thai , Christelle Lorenzato , Marie‐karelle Riviere , et al. Biometrics, 2022, ⟨10.1111/biom.13433⟩ Article dans une revue hal-03141298v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Bayesian sample size determination for phase IIA clinical trials using historical data and semi‐parametric prior's elicitation Paola Berchialla , Sarah Zohar , Ileana Baldi Pharmaceutical Statistics, 2018, 18 (2), pp.198-211. ⟨10.1002/pst.1914⟩ Article dans une revue hal-03862856v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Approaches to sample size calculation for clinical trials in rare diseases Frank Miller , Sarah Zohar , Nigel Stallard , Jason Madan , Martin Posch , et al. Pharmaceutical Statistics, 2018, 17 (3), pp.214-230. ⟨10.1002/pst.1848⟩ Article dans une revue hal-03864774v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		dfpk: An R-package for Bayesian dose-finding designs using pharmacokinetics (PK) for phase I clinical trials A. Toumazi , E. Comets , C. Alberti , T. Friede , F. Lentz , et al. Computer Methods and Programs in Biomedicine, 2018, 157, pp.163-177. ⟨10.1016/j.cmpb.2018.01.023⟩ Article dans une revue hal-03864772v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Decision-theoretic designs for small trials and pilot studies: A review Siew Wan Hee , Thomas Hamborg , Simon Day , Jason Madan , Frank Miller , et al. Statistical Methods in Medical Research, 2016, 25 (3), pp.1022-1038. ⟨10.1177/0962280215588245⟩ Article dans une revue inserm-02456662v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More

Filtrer vos résultats

Embedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experience

Coping with Information Loss and the Use of Auxiliary Sources of Data: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions

dfcomb: An R-package for phase I/II trials of drug combinations

Dose-finding methods for Phase I clinical trials using pharmacokinetics in small populations

Designs of drug-combination phase I trials in oncology: a systematic review of the literature

A dose finding design for seizure reduction in neonates

Using the continual reassessment method to estimate the minimum effective dose in phase II dose-finding studies: a case study

A straightforward meta‐analysis approach for oncology phase I dose‐finding studies

Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditions

Designing a paediatric study for an antimalarial drug including prior information from adults

Estimating Similarity of Dose–Response Relationships in Phase I Clinical Trials—Case Study in Bridging Data Package

Application of the Continual Reassessment Method to Dose-finding Studies in Regional Anesthesia

Bayesian variable selection based on clinical relevance weights in small sample studies—Application to colon cancer

Planning a Bayesian early-phase phase I/II study for human vaccines in HER2 carcinomas

Incorporating lower grade toxicity information into dose finding designs

Hematopoietic progenitor cell mobilization and harvesting in children with malignancies: do the advantages of pegfilgrastim really translate into clinical benefit?

Bayesian design and conduct of phase II single-arm clinical trials with binary outcomes: A tutorial

Recommendations for the design of therapeutic trials for neonatal seizures

Phase I/II dose-finding design for molecularly targeted agent: Plateau determination using adaptive randomization

Exploring how non-inferiority and equivalence are assessed in paediatrics: a systematic review

Approaches to sample size calculation for clinical trials in rare diseases

Response to comments on ‘Competing designs for drug combination in phase I dose-finding clinical trials’ by G. Yin, R. Lin and N. Wages

Comments on ‘A comparative study of adaptive dose-finding designs for phase I oncology trials of combination therapies’

Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue?

Dose-finding designs using a novel quasi-continuous endpoint for multiple toxicities

Bayesian dose‐regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics

Bayesian sample size determination for phase IIA clinical trials using historical data and semi‐parametric prior's elicitation

Approaches to sample size calculation for clinical trials in rare diseases

dfpk: An R-package for Bayesian dose-finding designs using pharmacokinetics (PK) for phase I clinical trials

Decision-theoretic designs for small trials and pilot studies: A review